Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.6884
-0.0246-3.45%
Post-market: 0.68890.0005+0.07%19:48 EDT
Volume:276.30K
Turnover:190.33K
Market Cap:86.84M
PE:-1.22
High:0.7119
Open:0.7044
Low:0.6650
Close:0.7130
Loading ...

Company Profile

Company Name:
Nautilus Biotechnolgy, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
155
Office Location:
2701 Eastlake Avenue East,Seattle,Washington,United States
Zip Code:
98102
Fax:
- -
Introduction:
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Directors

Name
Position
Adam Stone
Chief Executive Officer and Director
Joseph Edelman
Chairman
Michael Altman
Chief Financial Officer and Director
Bradley L. Campbell
Director
Saqib Islam
Director
Todd Wider
Director

Shareholders

Name
Position
Adam Stone
Chief Executive Officer and Director
Michael Altman
Chief Financial Officer and Director
Konstantin Poukalov
Chief Business Officer